A cutaneous gene therapy approach to treat infection through keratinocyte‐targeted overexpression of antimicrobial peptides

Infection represents a major associated problem in severely burned patients, as it causes skin graft failure and increases the risk of mortality. Topical and systemic antibiotic treatment is limited by the appearance of resistant bacterial strains. Antimicrobial peptides (AMPs) are gene‐ encoded “na...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2004-12, Vol.18 (15), p.1931-1933
Main Authors: Carretero, Marta, Río, Marcela, García, Marta, Escámez, María José, Mirones, Isabel, Rivas, Luis, Balague, Cristina, Jorcano, Jose Luis, Larcher, Fernando
Format: Article
Language:English
Subjects:
Adenoviridae - genetics
AMP
Anti-Bacterial Agents - biosynthesis
Antimicrobial Cationic Peptides - biosynthesis
Antimicrobial Cationic Peptides - genetics
burn wounds
Cell Line
Gene Expression
Genetic Therapy - methods
Genetic Vectors
Humans
In Vitro Techniques
Keratinocytes - metabolism
mulitdrug resistance
Skin - anatomy & histology
Skin - microbiology
Skin Diseases, Bacterial - therapy
Transduction, Genetic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Infection represents a major associated problem in severely burned patients, as it causes skin graft failure and increases the risk of mortality. Topical and systemic antibiotic treatment is limited by the appearance of resistant bacterial strains. Antimicrobial peptides (AMPs) are gene‐ encoded “natural antibiotics” that form part of the innate mechanism of defense and may be active against such antibiotic‐resistant microorganisms. Several microbicidal peptides are expressed in human skin under inflammatory conditions, and their function is not only limited to microbial killing but also influences tissue repair and adaptive immunity. Protein delivery through cutaneous gene therapy is a promising therapeutic tool for both skin and nonskin diseases. Here we present a gene transfer approach aimed at delivering antimicrobial peptides from keratinocytes. Adenoviral vectors encoding antimicrobial peptide genes were used to infect human keratinocytes growing either on plastic or as part of cultured skin equivalents. Inhibition of bacterial growth occurred both in conditioned media and in direct contact with AMPs gene‐ transduced keratinocytes. In addition, we showed cooperative effects after transfer of combinations of genes encoding for AMPs with structural differences. Combined cutaneous tissue engineering in conjunction with (microbicidal) gene therapy emerges as a tailored therapeutic approach that is useful for wound coverage and, in this case, concomitantly combating infection.
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.04-1515fje